Pfizer cuts earnings outlook on lower COVID-19 drug sales
The US pharmaceutical giant Pfizer sharply scaled back its earnings outlook for the year, blaming lower-than-expected sales of two drugs used to treat COVID-19, the company said Friday.
Oct 14, 2023
0
1